1124066

Mercury Clinical Research Inc — FEI 3016577643

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 18, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
745921 CFR 312.57(a)Records of receipt, shipment, disposition
748021 CFR 312.50Ensuring compliance with plan and protocol